Novel approaches in cancer study最新文献_第10页

New Ultrasonic Techniques for Colorectal Cancer Imaging 结直肠癌超声成像新技术

Novel approaches in cancer study Pub Date : 2019-06-24 DOI: 10.31031/nacs.2019.03.000552

R. Solleti, J. C. Machado

引用次数: 0

New Ultrasonic Techniques for Colorectal Cancer Imaging 癌症结直肠超声成像新技术

Novel approaches in cancer study Pub Date : 2019-06-24 DOI: 10.31031/NACS.2019.02.000552

R. Soletti

{"title":"New Ultrasonic Techniques for Colorectal Cancer Imaging","authors":"R. Soletti","doi":"10.31031/NACS.2019.02.000552","DOIUrl":"https://doi.org/10.31031/NACS.2019.02.000552","url":null,"abstract":"Colorectal cancer (CRC) is the third most common cancer diagnosed in the world and the second cancer-related cause of mortality in both men and women [1]. Despite of being about three times more incident in transitioned countries, the mortality rates for CRC are higher in transitioning countries, and these two discrepancies reflect that improvements in survival are due to the adoption of best practices in cancer treatment and management [2]. CRC presents a variation of incidence trends in different geographic regions: increasing incidence in some countries (such as China, Russia, Canada, The United Kingdom and Brazil) and decreasing incidence in others (including The United States, France and Japan) [3]. However, the overall declines in CRC incidence in countries such as The United States are masking an increasing incidence in young adults: from the mid1980 through 2013, rates of CRC incidence increased by 2.4% per year in adults aged 20-29 years and by 1.0% per year in adults aged 30-39 years [4]. It is estimated that by 2030 the incidence rates for colon and rectal cancer in the US population will increase by 90% and 124%, respectively, for patients 20 to 34 years of age [5]. The declining CRC incidence in groups aged older than 50 years may be a reflect from the widespread screening in this population, which rose from 38% in 2000 to 59% in 2013 [6]. Fecal occult blood tests, flexible sigmoidoscopy and colonoscopy were the most common screening test modalities among older adults in The United States until 2005 [7]. By 2005, colonoscopy had become the most common imaging screening test modality for CRC in older adults [7], with its use among US adults aged 50 years and older reaching 60% in 2015 [8].","PeriodicalId":93131,"journal":{"name":"Novel approaches in cancer study","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49400883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Acoustic Technology for Ctcs Isolation in Blood: Low-Cost Devices 血液中Ctcs的声学隔离技术：低成本装置

Novel approaches in cancer study Pub Date : 2019-06-19 DOI: 10.31031/NACS.2019.03.000551

Ivan Gonzalez, A. Pinto, Sergio Cuellar, J. Earl

引用次数: 0

Ultrasound Technology as a Novel Treatment Strategy in Pancreatic Cancer 超声技术作为癌症新的治疗策略

Novel approaches in cancer study Pub Date : 2019-06-17 DOI: 10.31031/NACS.2019.02.000550

Icíar González Gómez, A. R. Fernandez, L. Rodríguez-Lorenzo, Alberto Pinto del Corral, Luis M. Hérnandez, J. F. Díaz-Alejo, V. Olmos, C. Perna, J. Earl

引用次数: 1

Limitations of Immunotherapeutic Approaches for Cancer Treatment 癌症免疫治疗方法的局限性

Novel approaches in cancer study Pub Date : 2019-06-11 DOI: 10.31031/NACS.2019.02.000549

D. Amsterdam

引用次数: 0

Cancer Epigenetics: Shifting to More Deep Action 癌症表观遗传学：转向更深入的行动

Novel approaches in cancer study Pub Date : 2019-05-21 DOI: 10.31031/NACS.2019.02.000548

H. Sabit, S. Abdel-Ghany, E. Çevik, Ferhad Serag El-Deen

{"title":"Cancer Epigenetics: Shifting to More Deep Action","authors":"H. Sabit, S. Abdel-Ghany, E. Çevik, Ferhad Serag El-Deen","doi":"10.31031/NACS.2019.02.000548","DOIUrl":"https://doi.org/10.31031/NACS.2019.02.000548","url":null,"abstract":"Cancer is a large group of more 100 different diseases that can arise anywhere in the human body [1-3]. It involves uncontrolled cellular proliferation, with the potential to invade or spread to other parts of the body [4]. Cancer is considered the second common leading cause of death worldwide. This condition was responsible for about 9.6 million deaths in 2018, where about 1 in 6 deaths is due to cancer [5]. Cancer arises from accumulation of genetic mutations and/or epigenetic mutations [6,7]. Several genes are involved in the carcinogenesis process, and they are reported elsewhere. The most common causes of cancer are epimutations, where environmental pollutions are the main players [8,9]. Epigenetics is a kind of non-sequence dependent inheritance, where a change in the DNA methylation, histone modification, among others, might cause cancer to develop [10-12]. Different mechanisms are involved in epigenetic-mediated carcinogenesis, each of them was extensively studied during the last four decades [6]. Interestingly, newly developed epigenetic-based cancer therapies provide unique and validated approach to treat different types of cancers [13,14].","PeriodicalId":93131,"journal":{"name":"Novel approaches in cancer study","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42392994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cancer Might be Manifested by Short Breathing 癌症可能表现为呼吸短促

Novel approaches in cancer study Pub Date : 2019-05-21 DOI: 10.31031/NACS.2019.02.000547

Ramesh Sharma

{"title":"Cancer Might be Manifested by Short Breathing","authors":"Ramesh Sharma","doi":"10.31031/NACS.2019.02.000547","DOIUrl":"https://doi.org/10.31031/NACS.2019.02.000547","url":null,"abstract":"It is normally believed that the most causes of short breathing are due to heart and lung conditions, say asthma or allergic reactions or heart attack or low blood pressure or anemia or pneumonia or carbon monoxide poisoning or upper airway obstruction or blood clot in lungs; but chronic shortness of breath is most often due to asthma, chronic obstructive pulmonary disease, obesity, and lung diseases including the cancer of organ [1]. At this point the question arises, whether the chronic dyspnea (shortness of breath) is the symptom of lung cancer or might be its possible cause. However, it is found that people with advanced cancer (not only lung cancer) often get shortness of breath or dyspnea [2]. Therefore, the raised question is more generalized; whether chronic dyspnea is a cause or just a symptom of cancer. In other words, question arises, whether the dyspnea is the result of carcinogenic conditions in or cancer is caused by dyspnea state of the body. In 1986, Desigan et al. [3] tried to correlate progressive shortness of breath with manifestation of occult gastric cancer and stated that progressive shortness of breath may be the first or only manifestation of occult gastric cancer caused by either lymphangitic carcinomatosis or microscopic tumor emboli to the lungs. In this context, a further question arises, whether Desigan [3] statement might be generalized for various carcinogenic conditions in body. That means, might it be a true statement: progressive shortness of breath is the major manifestation of cancer or cancer is often manifested by progressive shortness of breath.","PeriodicalId":93131,"journal":{"name":"Novel approaches in cancer study","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45019614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Molecular Perspective of Clinical Benefit: Why Shouldn’t Luminal a Breast Cancer Patients be Considered in Pathological Complete Response Discussions 临床获益的分子视角:为什么在病理完全缓解讨论中不应考虑管腔A型乳腺癌患者

Novel approaches in cancer study Pub Date : 2019-05-16 DOI: 10.31031/NACS.2019.02.000546

I. Makhoul, T. KieberEmmons

引用次数: 0

Bridging the Gap between Pre-Clinical and Clinical Studies in Cancer Research 弥合癌症研究临床前和临床研究之间的差距

Novel approaches in cancer study Pub Date : 2019-05-09 DOI: 10.31031/NACS.2019.02.000545

R. Kumari

引用次数: 0

Modern Strategies in Cancer Study: Drug Repositioning in Colorectal Cancer Treatment 癌症研究的现代策略:大肠癌治疗中的药物重新定位

Novel approaches in cancer study Pub Date : 2019-05-07 DOI: 10.31031/NACS.2019.02.000544

A. Luciano, F. Malizia, Menacho Mm

引用次数: 5